Amino acid sequence requirements of Peptides that inhibit polyglutamine-protein aggregation and cell death

Biochemical and Biophysical Research Communications

Volumn 288, Issue 3, 2001, Pages 703-710

  Ren, H ^a   Nagai, Y ^a   Tucker, T ^a   Strittmatter, W J ^a   Burke, J R ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Ataxia; Ataxin; Huntington's disease; Intracellular delivery; Neurodegeneration; Phage display; Spinocerebellar; TAT; Therapy

Indexed keywords

POLYGLUTAMINE;

AMINO ACID SEQUENCE; ARTICLE; CELL DEATH; DENTATORUBROPALLIDOLUYSIAN ATROPHY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; NERVE DEGENERATION; PEPTIDE SYNTHESIS; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SPINOCEREBELLAR DEGENERATION;

ATAXIA;

EID: 0035798147     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.5783     Document Type: Article

References (26)

1. Polyglutamine disease and neuronal cell death
2. Molecular genetics: Unmasking pelyglutamine triggers in neuredegenerative disease
3. The CAG/polyglutamine tract diseases: Gene products and molecular pathogenesis
4. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats
5. Polyglutamine-mediated aggregation and cell death
6. Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions
7. Ataxin-1 nuclear localization and aggregation: Role in polyglutamine-induced disease in SCA1 transgenic mice
8. Evolution of amyloid: What normal protein folding may tell us about fibrillogenesis and disease
9. Interference by huntingtin and Atrophin-1 with CBP-Mediated transcription leading to cellular toxicity
10. Polyglutamine length-dependent interaction of Hsp40 and Hsp70 family chaperones with truncated N-terminal huntingtin: Their role in suppression of aggregation and cellular toxicity
11. Genetic suppression of polyglutamine toxicity in Drosophila
12. Huntington and DRPLA proteins selectively interact with the enzyme GAPDH
13. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias
14. Inhibition of polyglutamine protein aggregation and cell death by novel peptides identified by phage display screening
15. Messenger proteins: Homeoproteins, TAT and others
16. Arginine-rich peptides. An abundant source of membrane-permeable peptides having potential as carriers for intracellular protein delivery
17. In vivo protein transduction: Delivery of a biologically active protein into the mouse
18. Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases
19. Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4
20. Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy
21. Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides
22. Therapeutic opportunities in polyglutamine disease
23. Suppression of polyglutamine-mediated neurodegeneration in Drosophila by the molecular chaperone HSP70
24. CREB-binding protein sequestration by expanded polyglutamine
25. The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription
26. Models of amyloid seeding in Alzheimer's disease and scrapie - Mechanistic truths and physiologic consequences of the time-dependent solubility of amyloid proteins